CHARRAE BURDIN: Open Payments
NPI 1477888105 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 6 payments from 5 companies in 2025. Trend: 2023 $113 · 2024 $255 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 2 | $43 |
| Viatris Specialty LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ohtuvayre, YUPELRI, MOUNJARO, FARXIGA, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
